Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valvular Atrial Fibrillation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02941978
What this trial is testing

Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF)

Who this might be right for
Patient CompliancePatient Adherence
AHEPA University Hospital 1,140
Not applicableStudy completedNCT04681482
What this trial is testing

Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare

Who this might be right for
Atrial FibrillationObesityAnticoagulants
Pfizer 107,383
Not applicableNot Yet RecruitingNCT05263024
What this trial is testing

Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis

Who this might be right for
Atrial FibrillationThrombus; EmbolismWarfarin+2 more
Second Affiliated Hospital of Nanchang University 118
Not applicableUnknownNCT02356432
What this trial is testing

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)

Who this might be right for
Ischemic StrokeAtrial Fibrillation Symptomatic
Tokai University 86
Not applicableNot Yet RecruitingNCT07396493
What this trial is testing

A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)High Risk of Stroke
Shanghai Zhongshan Hospital 306
Not applicableUnknownNCT04297150
What this trial is testing

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

Who this might be right for
Atrial Fibrillation
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 700
Post-approval studies (Phase 4)Study completedNCT01438580
What this trial is testing

The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Nanjing Medical University 260
Large-scale testing (Phase 3)Ended earlyNCT03839355
What this trial is testing

Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Mayo Clinic 34
Not applicableLooking for participantsNCT02741349
What this trial is testing

Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Saint Antoine University Hospital 825
Not applicableStudy completedNCT03189069
What this trial is testing

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 36,000
Post-approval studies (Phase 4)UnknownNCT04135677
What this trial is testing

Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO

Who this might be right for
Left Atrial Appendage ThrombosisThrombiStroke
Shanghai Zhongshan Hospital 826
Not applicableStudy completedNCT03242278
What this trial is testing

Real-world Dosing Patterns of Rivaroxaban in the United States

Who this might be right for
Atrial Fibrillation
Bayer 12,507
Not applicableStudy completedNCT02921126
What this trial is testing

Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 9,914
Large-scale testing (Phase 3)Study completedNCT02942576
What this trial is testing

Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 632
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Not applicableStudy completedNCT03526471
What this trial is testing

Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Vascular Innovations Co. Ltd. 20
Not applicableLooking for participantsNCT06465459
What this trial is testing

Post-marketing Clinical Study of the LAMBRE System for Left Auricle Closure

Who this might be right for
Atrial Fibrillation
French Cardiology Society 220
Not applicableUnknownNCT03560219
What this trial is testing

Association of Genetic Polymorphisms With Atrial Fibrosis and Thrombogenic Substrate in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationThrombosisStroke+2 more
Memorial Ankara Hospital 225
Not applicableStudy completedNCT03258645
What this trial is testing

This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,489
Not applicableNot Yet RecruitingNCT06465706
What this trial is testing

Assessing the Safety and Efficacy of the LAmbre™ Plus Device

Who this might be right for
Atrial Fibrillation
Kansas City Heart Rhythm Research Foundation 1,826
Next Page